Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020Jeffrey J. Kooijman, Guido J.R. Zaman, Jelle Dylus et al.|Frontiers in Oncology|2022Cited by 22